D-0555-2024 Class II Ongoing
FDA drug recall D-0555-2024 was initiated by Eugia US LLC on May 23, 2024 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: impurity sulfonic acid adduct of dexamethasone phosphate results were above spec. The recall status is ongoing. Affected quantity: 70,125 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 26, 2024
- Initiation Date
- May 23, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 70,125 vials
Product description
Dexamethasone Sodium Phosphate injection USP, 120mg per 30mL (4mg/mL), 30 mL Multiple-Dose Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520, Made in India, NDC 55150-239-30
Reason for recall
Failed Impurities/Degradation Specifications: impurity sulfonic acid adduct of dexamethasone phosphate results were above spec.
Distribution pattern
USA Nationwide
Code information
Lot#: 3DS23001, 3DS23004, Exp 6/30/2024; 3DS23009, 3DS23011, Exp 7/31/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0555-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026